Scientific instruments manufacturer Formulaction has been acquired by Microtrac MRB, a Verder Group company
Microtrac MRB, the particle characterization segment of Verder Group, has acquired Formulaction, which will be integrated into the group’s scientific division.
Founded in 1994 by Gérard Meunier, Formulaction is a manufacturer of cutting-edge instrumentation used in research and development for the characterization of physical stability, particle size, phase transitions and rheological properties of liquid dispersions. Formulaction is the inventor of Turbiscan, the world reference in stability analysis. The company employs 36 people and is headquartered in Toulouse, France, supported by two subsidiaries in Columbus, Ohio, in the USA and Aichach, Germany.
Microtrac MRB is a subsidiary of Verder Group. A leading manufacturer of particle characterization instruments and technologies, Microtrac MRB’s products are used for measuring and analyzing particle size, shape, surface area and other properties in various industries, including pharmaceuticals, chemicals, minerals and materials research.
Verder Group is a global industrial company that specializes in manufacturing and distributing high-quality equipment and solutions for various industries, including laboratory, process and fluid handling. The group offers a wide range of products, such as pumps, mixers, samplers and analytical instruments.
After 25 years of development, Formulaction’s founder Gérard Meunier started to transfer responsibilities to key managers three years ago, anticipating the transaction for the group. After a competitive process involving strategic acquirors from all over the world, Verder Group was chosen as the best strategic fit to work alongside the company’s management. Verder Group has acquired 100% of shares.
Oaklins’ team in France served as the exclusive financial advisor to Formulaction’s shareholders throughout the sale process. The team approached several acquirors worldwide and negotiated the most attractive deal for the sellers.
Gérard Meunier
Founder, Formulaction
Prata med transaktionsteamet
Relaterade transaktioner
Sondrel secures a major investment
Sondrel has secured funding from Rox Equity Partners Ltd. through a subscription for new shares. The funds will enable the company to grow and expand its presence as one of the world’s leading providers of custom chip design and supply. In particular, it will help them rapidly develop their presence in the US.
Lär dig merLeika Medical Equipments Ltd. has been acquired by Angus Capital
The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.
Lär dig merPhen’X Technologies has sold a majority stake to Ciclad
The shareholders of Phen’X Technologies have completed a primary majority LBO with private equity fund Ciclad.
Lär dig mer